Log In

Forgot Password?
Create New Account

Loading... please wait

2024 Annual Meeting | N2 - Neuroscience in the Clinic: Neuromodulation: From Bench to Bedside

Sunday 04/14/24
01:00 PM - 03:00 PM MDT Add To Calendar
Colorado Convention Center | Mile High 1EF
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Neuroscience in the Clinic Session
Joshua M. Shulman, MD, PhD, FAAN, Viviana Gradinaru, PhD
Aging, Dementia, and Behavioral Neurology, Movement Disorders, Movement Disorders
2.00 CME credits
Brain Health

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:03 PM MDT Introduction Introduction
Joshua M. Shulman, MD, PhD, FAAN
01:03 PM - 01:28 PM MDT Speaker Blood-brain Barrier: Friend and Foe—Towards Targeted, Noninvasive Study and Repair of Nervous Systems
Viviana Gradinaru, PhD
01:28 PM - 01:53 PM MDT Speaker Ultrasonic Drug Uncaging for Noninvasive Targeted Neuro-pharmacology
Raag Airan
01:53 PM - 02:18 PM MDT Speaker Circuit-Inspired Strategies to Improve Treatments for Parkinson’s Disease
Aryn Gittis
02:18 PM - 02:30 PM MDT Abstract 001 - Phase 1b Safety and Preliminary Efficacy of Bilateral Intraputaminal Delivery of AAV2 GDNF (AB-1005) in Participants With Mild or Moderate Parkinson’s Disease
Amber D. Van Laar, MD
02:30 PM - 02:42 PM MDT Abstract 002 - Cognito’s non-invasive medical device demonstrates durable effects on activities of daily living through OVERTURE open-label extension study.
Ralph Z. Kern, MD
02:42 PM - 03:00 PM MDT Discussion Discussion and Panel Q&A
Joshua M. Shulman, MD, PhD, FAAN, Viviana Gradinaru, PhD, Raag Airan, Aryn Gittis
Faculty Disclosures
Joshua M. Shulman, MD, PhD, FAAN Dr. Shulman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Shulman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Helis Medical Foudation. The institution of Dr. Shulman has received research support from National Institutes of Health.
Viviana Gradinaru, PhD Viviana Gradinaru, PhD has nothing to disclose.
Raag Airan No disclosure on file
Aryn Gittis No disclosure on file
Ralph Z. Kern, MD Dr. Kern has received personal compensation for serving as an employee of Cognito Therapeutics.
ZD Kuang No disclosure on file
Mihaly Hajos, PhD Prof. Hajos has received personal compensation for serving as an employee of Cognito Therapeutics, Inc. Prof. Hajos has stock in Cognito Therapeuitcs. Prof. Hajos has stock in Biogen. Prof. Hajos has stock in Pfizer. Prof. Hajos has received intellectual property interests from a discovery or technology relating to health care.
Alex Konisky No disclosure on file
Alyssa Boasso No disclosure on file
Evan Hempel No disclosure on file
Brent Vaughan No disclosure on file
Chandran Seshagiri No disclosure on file
Zach Malchano Mr. Malchano has received personal compensation for serving as an employee of Cognito Therapeutics, Inc.. Mr. Malchano has received stock or an ownership interest from Cognito Therapeutics.
Suzanne Hendrix, PhD Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has stock in Pentara.
Khalil Saikali No disclosure on file
Joseph Massey No disclosure on file
Ramesh Arjunji No disclosure on file
Amber D. Van Laar, MD Dr. Van Laar has received personal compensation for serving as an employee of Asklepios Biopharmaceutical. The institution of an immediate family member of Dr. Van Laar has received research support from Asklepios BioPharmaceutical Inc.
Chadwick W. Christine, MD, FAAN The institution of Dr. Christine has received research support from Neurocrine Biosciences. The institution of Dr. Christine has received research support from Brain Neurotherapy Bio, Inc. The institution of Dr. Christine has received research support from Michael J Fox Foundation for Parkinson's Research. The institution of Dr. Christine has received research support from Annovis Bio. The institution of Dr. Christine has received research support from Aspen Neurosciences.
Aristide Merola, MD, PhD Dr. Merola has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Merola has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Merola has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Nicolás Phielipp, MD No disclosure on file
Bradley Elder No disclosure on file
Paul Larson No disclosure on file
Waldy San Sebastian No disclosure on file
Adrian Kells No disclosure on file
Massimo Fiandaca No disclosure on file
Krystof Bankiewicz No disclosure on file